2.2. Patients
cancer
CANCER
The intervention group enrolled patients already included in the phase II CINCAN-2 study [Eligible patients were 18 years or older, diagnosed with cancer, chemotherapy-naïve, and scheduled to receive at least 4 cycles of paclitaxel- or oxaliplatin-based chemotherapy. Patients unable to answer patient-reported outcome (PRO) measurements, unable to cooperate with the study procedures and patients already using cannabis were ineligible.The study was not randomized but used a control group of patients receiving the same kind of chemotherapy. The control group fulfilled the same inclusion and exclusion criteria as the intervention group but did not receive CBD.Patients in the control group (